| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.9M | +289.8% |
| Cost of Revenue | $153.3M | +229.6% |
| R&D Expense | $18.5M | -3.8% |
| SG&A Expense | $60.6M | +41.0% |
| Operating Income | -$221.3M | -64.2% |
| Pre-tax Income | -$229.8M | -85.0% |
| Income Tax | $51K | — |
| Net Income | -$229.8M | -85.0% |
| EPS (Basic) | -$3.68 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.1M | -83.7% |
| Accounts Receivable | $1.7M | -13.0% |
| Inventory | $23.3M | +79.3% |
| Current Assets | $55.1M | -61.3% |
| Total Assets | $106.8M | -36.9% |
| Current Liabilities | $60.6M | +102.5% |
| Long-term Debt | $175.8M | +2659.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$196.9M | -69.5% |
| Capital Expenditures | $20.1M | +28.8% |
| Investing Cash Flow | -$17.2M | +26.4% |
| Financing Cash Flow | $139.5M | +13.2% |
| Free Cash Flow | -$216.9M | -64.7% |
| -55.9% |
| EPS (Diluted) | -$3.68 | -55.9% |
| Total Liabilities |
| $239.5M |
| +75.2% |
| Stockholders' Equity | -$132.7M | -509.0% |